These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 14688363)

  • 1. IL-23 induces stronger sustained CTL and Th1 immune responses than IL-12 in hepatitis C virus envelope protein 2 DNA immunization.
    Ha SJ; Kim DJ; Baek KH; Yun YD; Sung YC
    J Immunol; 2004 Jan; 172(1):525-31. PubMed ID: 14688363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
    Wozniak TM; Ryan AA; Triccas JA; Britton WJ
    Infect Immun; 2006 Jan; 74(1):557-65. PubMed ID: 16369012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes.
    Chow YH; Chiang BL; Lee YL; Chi WK; Lin WC; Chen YT; Tao MH
    J Immunol; 1998 Feb; 160(3):1320-9. PubMed ID: 9570550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine genetic adjuvant facilitates prophylactic intravascular DNA vaccine against acute and latent herpes simplex virus infection in mice.
    Cui FD; Asada H; Jin ML; Kishida T; Shin-Ya M; Nakaya T; Kita M; Ishii M; Iwai M; Okanoue T; Imanishi J; Mazda O
    Gene Ther; 2005 Jan; 12(2):160-8. PubMed ID: 15470476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ag85B of mycobacteria elicits effective CTL responses through activation of robust Th1 immunity as a novel adjuvant in DNA vaccine.
    Takamura S; Matsuo K; Takebe Y; Yasutomi Y
    J Immunol; 2005 Aug; 175(4):2541-7. PubMed ID: 16081827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering of N-glycosylation of hepatitis C virus envelope protein E2 enhances T cell responses for DNA immunization.
    Li P; Wan Q; Feng Y; Liu M; Wu J; Chen X; Zhang XL
    Vaccine; 2007 Feb; 25(8):1544-51. PubMed ID: 17055129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice.
    Matsui M; Moriya O; Belladonna ML; Kamiya S; Lemonnier FA; Yoshimoto T; Akatsuka T
    J Virol; 2004 Sep; 78(17):9093-104. PubMed ID: 15308705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective induction of type 1 cytotoxic T cell responses in mice with DNA vaccine encoding two hepatitis C virus cytotoxic T lymphocyte epitopes.
    Shi L; Liu S; Fan GX; Sheng L; Ren HX; Yuan YK
    Viral Immunol; 2006; 19(4):702-11. PubMed ID: 17201665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine.
    Xin KQ; Hamajima K; Sasaki S; Tsuji T; Watabe S; Okada E; Okuda K
    Vaccine; 1999 Feb; 17(7-8):858-66. PubMed ID: 10067692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-glycosylation-mutated HCV envelope glycoprotein complex enhances antigen-presenting activity and cellular and neutralizing antibody responses.
    Ren Y; Min YQ; Liu M; Chi L; Zhao P; Zhang XL
    Biochim Biophys Acta; 2016 Aug; 1860(8):1764-75. PubMed ID: 26278021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
    Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
    J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
    Wild J; Grusby MJ; Schirmbeck R; Reimann J
    J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-23 production by cosecretion of endogenous p19 and transgenic p40 in keratin 14/p40 transgenic mice: evidence for enhanced cutaneous immunity.
    Kopp T; Lenz P; Bello-Fernandez C; Kastelein RA; Kupper TS; Stingl G
    J Immunol; 2003 Jun; 170(11):5438-44. PubMed ID: 12759419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of N-glycosylation sites of hepatitis C virus envelope protein E1 enhances specific cellular and humoral immune responses.
    Liu M; Chen H; Luo F; Li P; Pan Q; Xia B; Qi Z; Ho WZ; Zhang XL
    Vaccine; 2007 Sep; 25(36):6572-80. PubMed ID: 17675185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral and CD4(+) T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant protein.
    Lazdina U; Hultgren C; Frelin L; Chen M; Lodin K; Weiland O; Leroux-Roels G; Quiroga JA; Peterson DL; Milich DR; Sällberg M
    J Gen Virol; 2001 Jun; 82(Pt 6):1299-1308. PubMed ID: 11369873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The secreted form of the p40 subunit of interleukin (IL)-12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effects.
    Shimozato O; Ugai S; Chiyo M; Takenobu H; Nagakawa H; Wada A; Kawamura K; Yamamoto H; Tagawa M
    Immunology; 2006 Jan; 117(1):22-8. PubMed ID: 16423037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of immunoglobulin G2a and cytotoxic T-lymphocyte responses by a booster immunization with recombinant hepatitis C virus E2 protein in E2 DNA-primed mice.
    Song MK; Lee SW; Suh YS; Lee KJ; Sung YC
    J Virol; 2000 Mar; 74(6):2920-5. PubMed ID: 10684312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of cellular responses by plasmid CD40L: CD40L plasmid vectors enhance antigen-specific helper T cell type 1 CD4+ T cell-mediated protective immunity against herpes simplex virus type 2 in vivo.
    Sin JI; Kim JJ; Zhang D; Weiner DB
    Hum Gene Ther; 2001 Jun; 12(9):1091-102. PubMed ID: 11399230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical components of a DNA fusion vaccine able to induce protective cytotoxic T cells against a single epitope of a tumor antigen.
    Rice J; Buchan S; Stevenson FK
    J Immunol; 2002 Oct; 169(7):3908-13. PubMed ID: 12244189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of immune response to a hepatitis C virus E2 DNA vaccine by an immunoglobulin Fc fusion tag.
    Sun W; Li Q; Zhu D; Feng J; Zhuang Z; Sun X; Xiao G; Duan Y
    J Med Virol; 2015 Dec; 87(12):2090-7. PubMed ID: 26010499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.